A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
This study is designed to confirm if 8mg of fesoterodine is more effective in reducing overactive bladder symptoms than 4mg of fesoterodine. In addition the study is designed to assess if the higher dose reduces the overall effect of overactive bladder on the subject's daily life more than the lower dose. The study also assesses the side effects and safety of the two doses.
Inclusion Criteria:
Exclusion Criteria:
Idaho Falls, Idaho 83404, United States
Winston-Salem, North Carolina 27103, United States
State College, Pennsylvania 16801, United States
North York, Ontario M2J 1V1, Canada
Bogota, Cundinamarca 0000, Colombia
Praha 1 - Nove Mesto, 110 00, Czechia
Praha 6 - Hradcany, 160 00, Czechia
Muelheim A.d. Ruhr, 45468, Germany
NyĂregyháza, 4400, Hungary
Gdansk, 80-402, Poland
Barnaul, 656038, Russia
Saint Petersburg, 199034, Russia
Považská Bystrica, 017 01, Slovakia
Seoul, 120-752, South Korea
Seoul, 137-701, South Korea
Chernivtsi, 58002, Ukraine
Donetsk, Ukraine
Donetsk, Ukraine
Hertfordshire, WD2 6EB, United Kingdom